“…Nineteen studies were retrospective [ 38 , 39 , 41 – 47 , 49 – 55 , 57 – 59 ], whilst the remaining three did not report the study design [ 40 , 48 , 56 ]. Clinical endpoints included disease severity based on current clinical guidelines (13 studies) [ 39 , 41 , 43 , 45 – 48 , 50 – 52 , 55 , 59 ], disease progress (two studies) [ 40 , 56 ], occurrence of ARDS (one study) [ 54 ], and survival (six studies) [ 38 , 42 , 44 , 49 , 57 , 58 ]. In all studies, serum HBDH concentrations were measured on admission.…”